DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1155727
Title:
Treatment Options and Survival of Metastatic Prostate Cancer Patients
Descriptive Note:
[Technical Report, Annual Report]
Corporate Author:
The Washington University
Report Date:
2021-06-01
Pagination or Media Count:
10
Abstract:
In this proposal, we will utilize a prostate cancer cohort from the VA hospitals to explore the survival benefit among men diagnosed with metastatic prostate cancer who receive definitive treatment alone or with adjuvant therapies compared to men who receive non-definitive treatment and we will assess the treatment related side effects that affect quality of life among men diagnosed with metastatic prostate cancer who receive definitive vs. non-definitive treatment. The specific aims are Aim 1 To examine the survival benefit among men diagnosed with metastatic prostate cancer that receive definitive treatment compared to men that receive non-definitive treatment. Aim 2 To examine treatment-related side effects that affect quality of life impotence, incontinence and pain among men diagnosed with metastatic prostate cancer that receive definitive treatment compared to men that receive non-definitive treatment.
Distribution Statement:
[A, Approved For Public Release]
